Gilead Sciences Inc (NASDAQ:GILD)

63.15
Delayed Data
As of Jan 24
 -0.79 / -1.24%
Today’s Change
60.89
Today|||52-Week Range
70.50
-2.82%
Year-to-Date
An Emboldened Bristol-Myers Squibb Wants $1.5 Billion From Gilead Sciences
Jan 24 / MotleyFool.com - Paid Partner Content
2 Dividend-Paying Biotech Stocks Worth Owning in 2020
Jan 23 / MotleyFool.com - Paid Partner Content
Better Buy: Amgen vs. Gilead Sciences
Jan 24 / MotleyFool.com - Paid Partner Content
Where Will Intercept Pharmaceuticals Be in 5 Years?
Jan 23 / MotleyFool.com - Paid Partner Content
Gilead Considering Ebola Drug as Potential Coronavirus Treatment
Jan 23 / MotleyFool.com - Paid Partner Content
2 Small-Cap Biotech Stocks to Watch in 2020
Jan 23 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close63.94
Today’s open64.07
Day’s range62.84 - 64.20
Volume18,685,066
Average volume (3 months)6,775,147
Market cap$79.7B
Data as of 4:00pm ET, 01/24/2020

Growth & Valuation

Earnings growth (last year)+18.69%
Earnings growth (this year)+5.07%
Earnings growth (next 5 years)+3.83%
Revenue growth (last year)-15.00%
P/E ratio29.8
Price/Sales3.68
Price/Book3.77

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen-6.07-2.14%
ILMNIllumina Inc-7.42-2.27%
AMGNAmgen-9.45-4.02%
BMRNBiomarin Pharmaceuti...+0.52+0.61%
Data as of 4:00pm ET, 01/24/2020

Financials

Next reporting dateFebruary 5, 2020
EPS forecast (this quarter)$1.67
Annual revenue (last year)$22.2B
Annual profit (last year)$5.5B
Net profit margin24.56%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Foster City, California

Forecasts